Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment
- PMID: 28474414
- DOI: 10.1002/hed.24607
Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment
Abstract
Background: Clinical perineural invasion (PNI) of the trigeminal and facial nerves from cutaneous head and neck squamous cell carcinoma (cutaneous HNSCC) is a rare clinical entity that poses unique therapeutic challenges.
Methods: A retrospective chart review of a skull base oncology database was performed of patients with the diagnosis of clinical PNI from a cutaneous HNSCC. Patients who were previously untreated underwent multimodal treatment entailing surgical resection and postoperative radiotherapy (PORT) and patients who were previously treated with radiotherapy underwent salvage surgical resection between the years 2006 and 2012. Survival outcomes, such as disease-free survival (DFS) and overall survival (OS), were analyzed and correlated with surgical factors, such as margin status, previous treatment, zone involvement, and trigeminal involvement (branch-specific), as well as the pretreatment and posttreatment pain scores.
Results: Of 21 patients with clinical PNI from cutaneous HNSCC, 7 patients (33%) were previously treated for their disease with primary radiotherapy. Negative tumor margins were achieved in 18 patients (86%). Three of the 7 patients (43%) undergoing salvage surgery had positive margins. One-year and 3-year DFS for previously untreated patients was 91% and 67%, respectively, whereas 1-year and 3-year DFS was 72% and 28%, respectively, for the previously treated patients. Previous radiotherapy, ophthalmic nerve involvement, and positive margins portended poorer survival outcomes in this study.
Conclusion: The retrospective study of this rare clinical entity demonstrates that multimodal treatment can achieve favorable survival outcomes. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1280-1286, 2017.
Keywords: cranial nerve palsy; cutaneous; head and neck; multimodal treatment; perineural invasion; squamous cell carcinoma.
© 2017 Wiley Periodicals, Inc.
Similar articles
-
Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.J Am Acad Dermatol. 2015 Aug;73(2):221-7. doi: 10.1016/j.jaad.2015.04.037. Epub 2015 May 29. J Am Acad Dermatol. 2015. PMID: 26028524
-
Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.JAMA Dermatol. 2019 Apr 1;155(4):442-447. doi: 10.1001/jamadermatol.2018.5453. JAMA Dermatol. 2019. PMID: 30810715 Free PMC article.
-
Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma.Head Neck. 2016 Jun;38(6):824-31. doi: 10.1002/hed.23982. Epub 2015 May 6. Head Neck. 2016. PMID: 25546817
-
Advanced concepts in the imaging of perineural spread of tumor to the trigeminal nerve.Top Magn Reson Imaging. 1999 Dec;10(6):376-83. doi: 10.1097/00002142-199912000-00004. Top Magn Reson Imaging. 1999. PMID: 10643881 Review.
-
Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology.Head Neck. 2017 Mar;39(3):578-594. doi: 10.1002/hed.24580. Epub 2016 Nov 24. Head Neck. 2017. PMID: 27882625 Review.
Cited by
-
Durable tumor regression and restoration of neurologic function after treatment with anti-PD-1 in patients with functionally unresectable cutaneous squamous cell carcinoma with perineural spread into the cavernous sinus.J Neurooncol. 2023 Sep;164(2):431-436. doi: 10.1007/s11060-023-04427-y. Epub 2023 Sep 1. J Neurooncol. 2023. PMID: 37656376
-
Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.Dtsch Arztebl Int. 2019 Sep 13;116(37):616-626. doi: 10.3238/arztebl.2019.0616. Dtsch Arztebl Int. 2019. PMID: 32048593 Free PMC article. Review.
-
Diagnostic Accuracy of Contrast-Enhanced MRI for Detection of Perineural Spread in Head and Neck Cancer: A Systematic Review and Meta-Analysis.J Neurol Surg B Skull Base. 2023 Dec 22;85(Suppl 2):e97-e109. doi: 10.1055/s-0043-1777793. eCollection 2024 Oct. J Neurol Surg B Skull Base. 2023. PMID: 39444772 Free PMC article.
-
Cutaneous Squamous Cell Carcinoma of the Head and Neck: Pathological Features and What They Mean for Prognosis and Treatment.Cancers (Basel). 2024 Aug 17;16(16):2866. doi: 10.3390/cancers16162866. Cancers (Basel). 2024. PMID: 39199636 Free PMC article. Review.
-
MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation.PLoS One. 2020 Nov 23;15(11):e0241551. doi: 10.1371/journal.pone.0241551. eCollection 2020. PLoS One. 2020. PMID: 33227008 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical